Current Ratio

The current ratio measures a company’s ability to pay short-term obligations with its short-term assets; a value of 0.55x means bluebird bio has only $0.55 in current assets for every $1.00 of current liabilities, indicating potential liquidity pressure.

This figure sits well below the healthcare sector median of 2.06x and places the company at the 0th percentile among its peers, meaning no other peer has a lower current ratio. Trend data is not available (N/A) for the year-over-year change, quarter-over-quarter change, or the last eight quarters, so no directional pattern can be assessed. The combination of a very low ratio with no observable trend suggests heightened short-term risk, as the company may struggle to cover immediate liabilities without raising capital or restructuring. This metric contradicts the overall NEUTRAL verdict by highlighting a specific weakness in financial flexibility, though a neutral stance could still be justified if other factors (e.g., future product revenue) offset this concern.

Frequently Asked Questions

Closest Sector Peers